Guess who will be partnering with the US Department of Veterans Affairs to support its wider use of digital pathology? It’s Google! Last month, it was announced that the Defense Innovation Unit (DIU) of the Department of Defense (DoD) had selected Google Cloud “to prototype an artificial intelligence-enabled digital pathology solution to help detect cancer on multiple disease areas.” This relationship can be expected to encourage acceptance and wider use of digital pathology by pathologists throughout the United States.
MORE ON: VA and Digital Pathology
In the joint press release, the two partners wrote that the digital pathology project “includes the delivery of augmented reality microscopes to DoD’s medical facilities and access to artificial intelligence (AI) models that can help military doctors with cancer detection tasks on multiple disease areas. The early access to the digital pathology platform is for research use only … The initial rollout will take place at select Defense Health Agency treatment facilities and Veteran’s Affairs hospitals in the United States, with future plans to expand across the broader U.S. Military Health System.”
CALIF. GOVERNOR VETOS GENETIC BILL
California’s “Genetic Information Privacy Act” (SB 980) will not become law. It was vetoed on September 25, 2020, by Governor Gavin Newsom. The bill was intended to define requirements for how entities, including direct-to-consumer (DTC) genetic testing companies, collect, handle, and share genetic information. California’s legislature is often first to propose and pass legislation that is then used as a model for other states when developing their own bills on the same subject.
• Rick Panning retired from his position as Senior Administrative Director of Laboratory Services at HealthPartners/Park Nicollet in Minneapolis. He previously served at Fairview Health Services, Allina, and American Red Cross. He is a past president of the American Society of Clinical Laboratory Sciences.
• Biofidelity of Cambridge, England, announced the selection of Stephen Miller as Chief Commercial Officer. Miller formerly held positions at Precipio, Transgenomic, BG Medicine, and Athena Diagnostics.
• Neogenomics, Inc., of Fort Meyers, Fla., selected Madhushree Ghosh as its new Vice President, Strategic Alliances and Projects, Pharma Services. She previously served at Thermo Fisher Scientific, AltheaDx, and Qiagen.
That’s all the insider intelligence for this report. Look for the next briefing on Monday, October 26, 2020.